Davis Rea LTD. Has $14.51 Million Stock Holdings in Synopsys, Inc. $SNPS

Key Points

• Davis Rea LTD. reduced its stake by 13.9% in Synopsys during Q4 to 30,889 shares worth $14.51 million, representing 3.6% of the firm's holdings and the stock being its eighth-largest position.
• Synopsys beat quarterly estimates with $3.77 EPS vs. $3.56 expected and $2.41 billion in revenue (up 65.6% YoY), and issued FY2026 guidance of $14.38–$14.46 EPS.
• Analysts are mixed—Synopsys has an average rating of "Hold" with an average target of $531; the shares trade near $456.85 (down ~4.3%), with a market cap around $87.5 billion and a P/E near 71.

Davis Rea LTD. lessened its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 13.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 30,889 shares of the semiconductor company's stock after selling 4,994 shares during the period. Synopsys accounts for 3.6% of Davis Rea LTD.'s holdings, making the stock its 8th biggest holding. Davis Rea LTD.'s holdings in Synopsys were worth $14,509,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Alpine Bank Wealth Management raised its stake in Synopsys by 89.3% during the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company's stock worth $26,000 after buying an additional 25 shares during the last quarter. TFC Financial Management Inc. raised its stake in Synopsys by 1,250.0% during the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company's stock worth $27,000 after buying an additional 50 shares during the last quarter. Millstone Evans Group LLC bought a new position in Synopsys during the third quarter worth $27,000. SOA Wealth Advisors LLC. bought a new position in Synopsys during the third quarter worth $28,000. Finally, Thurston Springer Miller Herd & Titak Inc. bought a new position in Synopsys during the fourth quarter worth $28,000. Institutional investors own 85.47% of the company's stock.

Synopsys Trading Down 4.3%

NASDAQ:SNPS opened at $456.85 on Friday. The company has a current ratio of 1.36, a quick ratio of 1.26 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $87.51 billion, a price-to-earnings ratio of 70.94, a PEG ratio of 3.90 and a beta of 1.15. The firm has a fifty day simple moving average of $424.75 and a two-hundred day simple moving average of $445.17. Synopsys, Inc. has a 12 month low of $376.18 and a 12 month high of $651.73.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping analysts' consensus estimates of $3.56 by $0.21. The business had revenue of $2.41 billion during the quarter, compared to analysts' expectations of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The business's quarterly revenue was up 65.6% on a year-over-year basis. During the same period last year, the company posted $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Analysts expect that Synopsys, Inc. will post 10.3 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on SNPS. Needham & Company LLC reissued a "buy" rating on shares of Synopsys in a research note on Thursday, February 26th. Piper Sandler lowered their target price on shares of Synopsys from $520.00 to $430.00 and set a "neutral" rating for the company in a research note on Thursday, February 26th. Weiss Ratings reissued a "hold (c)" rating on shares of Synopsys in a research note on Thursday, January 22nd. The Goldman Sachs Group set a $600.00 target price on shares of Synopsys and gave the stock a "buy" rating in a research note on Wednesday, February 25th. Finally, Rosenblatt Securities lowered their target price on shares of Synopsys from $560.00 to $530.00 and set a "buy" rating for the company in a research note on Thursday, February 26th. Eight analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Synopsys currently has an average rating of "Hold" and an average target price of $531.00.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.